Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia

La resistencia bacteriana es un problema de carácter mundial que pone en riesgo la salud humana y agota las opciones terapéuticas contra bacterias patógenas multiresistentes a los antibióticos. La resistencia a la colistina estaba asociada a mutaciones cromosomales, sin embargo, en el año 2015 repor...

Full description

Autores:
Mahecha López, Mateo
Velandia López, Ana María
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2021
Institución:
Colegio Mayor de Cundinamarca
Repositorio:
Repositorio Colegio Mayor de Cundinamarca
Idioma:
spa
OAI Identifier:
oai:repositorio.unicolmayor.edu.co:unicolmayor/5552
Acceso en línea:
https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5552
Palabra clave:
Resistencia bacteriana
E. coli
Colistina
mcr-1
Rights
closedAccess
License
Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
id UCOLMAYOR2_2e7f3e9b9714e8b687ad447642fb2760
oai_identifier_str oai:repositorio.unicolmayor.edu.co:unicolmayor/5552
network_acronym_str UCOLMAYOR2
network_name_str Repositorio Colegio Mayor de Cundinamarca
repository_id_str
dc.title.spa.fl_str_mv Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia
title Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia
spellingShingle Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia
Resistencia bacteriana
E. coli
Colistina
mcr-1
title_short Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia
title_full Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia
title_fullStr Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia
title_full_unstemmed Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia
title_sort Caracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia
dc.creator.fl_str_mv Mahecha López, Mateo
Velandia López, Ana María
dc.contributor.advisor.none.fl_str_mv Pinilla Bermúdez, Gladys
De La Cadena Vivas, Elsa Piedad
dc.contributor.author.none.fl_str_mv Mahecha López, Mateo
Velandia López, Ana María
dc.subject.lemb.none.fl_str_mv Resistencia bacteriana
E. coli
topic Resistencia bacteriana
E. coli
Colistina
mcr-1
dc.subject.proposal.spa.fl_str_mv Colistina
mcr-1
description La resistencia bacteriana es un problema de carácter mundial que pone en riesgo la salud humana y agota las opciones terapéuticas contra bacterias patógenas multiresistentes a los antibióticos. La resistencia a la colistina estaba asociada a mutaciones cromosomales, sin embargo, en el año 2015 reportaron por primera vez el gen mcr-1 que genera resistencia a polimixinas a través de plásmidos. Después de este, se han realizado reportes prácticamente por todo el mundo, asociados tanto a aislamientos de origen animal como humanos. En Colombia fue detectado por primera vez en el año 2016 en tres aislamientos de Salmonella entérica serovar Typhimurium y un aislamiento de E. coli. En esta investigación se estudiaron 32 aislados de E. coli recolectados de instituciones hospitalarias de tercer nivel en Colombia con el objetivo de determinar las características genéticas y fenotipicas de resistencia.De los 32 aislamientos estudiados, se confirmaron 7 como resistentes a colistina por metodología CBDE. La PCR mostro que 5 de los 7 aislados portaban genes mcr-1,uno de estos con fenotipo BLEE resistente a ceftriaxona, cefotaxime y susceptibilidad reducida a ceftazidime y confirmación de CTXM-55 por SGC.Dos aislamientos presentaron clonalidad del 100% por PFGE, la mayoria de aislados con grupo filogenético B1 y dos compartiendo el mismo MLST, se detectaron distintos plasmidos con predominio IncFII y dentro de su entorno genético se pudo identificar un aislado portando mcr-1 posiblemente en un plasmido tipo Incl.
publishDate 2021
dc.date.issued.none.fl_str_mv 2021-09-03
dc.date.accessioned.none.fl_str_mv 2022-05-11T00:27:05Z
dc.date.available.none.fl_str_mv 2022-05-11T00:27:05Z
dc.type.spa.fl_str_mv Trabajo de grado - Pregrado
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/TP
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_7a1f
status_str publishedVersion
dc.identifier.uri.none.fl_str_mv https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5552
url https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5552
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect Dis [Internet]. 2016 Feb 1 [cited 2020 Sep 28];16(2):161–8. Available from: http://www.thelancet.com/article/S1473309915004247/fulltext
Saavedra SY, Diaz L, Wiesner M, Correa A, Alejandra Arévalo S, Reyes J, et al. Genomic and molecular characterization of clinical isolates of Enterobacteriaceae harboring mcr-1 in Colombia, 2002 to 2016. Antimicrob Agents Chemother [Internet]. 2017 Dec 1 [cited 2020 Sep 28];61(12). Available from: http://aac.asm.org/
Velasco JMS, Valderama MTG, Margulieux KR, Diones PCS, Reyes AMB, Leonardia SG, et al. First report of the mcr-1 colistin resistance gene identified in two Escherichia coli isolates from clinical samples, Philippines, 2018. J Glob Antimicrob Resist. 2020 Jun 1;21:291–3.
Amin MB, Sraboni AS, Hossain MI, Roy S, Mozmader TAU, Unicomb L, et al. Occurrence and genetic characteristics of mcr-1-positive colistin-resistant E. coli from poultry environments in Bangladesh. J Glob Antimicrob Resist. 2020 Sep 1;22:546–52.
Vounba P, Rhouma M, Arsenault J, Bada Alambédji R, Fravalo P, Fairbrother JM. Prevalence of colistin resistance and mcr-1/mcr-2 genes in extended-spectrum β-lactamase/AmpC-producing Escherichia coli isolated from chickens in Canada, Senegal and Vietnam. J Glob Antimicrob Resist. 2019 Dec 1;19:222–7.
Zhang H, Srinivas S, Xu Y, Wei W, Feng Y. Genetic and Biochemical Mechanisms for Bacterial Lipid A Modifiers Associated with Polymyxin Resistance [Internet]. Vol. 44, Trends in Biochemical Sciences. Elsevier Ltd; 2019 [cited 2020 Sep 28]. p. 973–88. Available from: http://www.cell.com/article/S0968000419301355/fulltext
Ezadi F, Ardebili A, Mirnejad R. Antimicrobial susceptibility testing for polymyxins: Challenges, issues, and recommendations [Internet]. Vol. 57, Journal of Clinical Microbiology. American Society for Microbiology; 2018 [cited 2020 Sep 28]. Available from: https://jcm.asm.org/content/57/4/e01390-18
Bell DT, Bergman Y, Kazmi AQ, Lewis S, Tamma PD, Simner PJ. A novel phenotypic method to screen for plasmid-mediated colistin resistance among enterobacteriales. J Clin Microbiol [Internet]. 2019 May 1 [cited 2020 Sep 28];57(5). Available from: https://doi.org/10.1128/JCM.00040-19.
Lerminiaux NA, Cameron ADS. Horizontal transfer of antibiotic resistance genes in clinical environments. Can J Microbiol [Internet]. 2019 Jan [cited 2020 Sep 28];65(1):34–44. Available from: http://www.nrcresearchpress.com/doi/10.1139/cjm-2018-0275
Tarabai H, Valcek A, Jamborova I, Vazhov S V., Karyakin I V., Raab R, et al. Plasmid-mediated mcr-1 colistin resistance in Escherichia coli from a black kite in Russia. Antimicrob Agents Chemother [Internet]. 2019 Sep 1 [cited 2020 Sep 28];63(9). Available from: https://doi.org/10.1128/AAC
Nang SC, Li J, Velkov T. The rise and spread of mcr plasmid-mediated polymyxin resistance [Internet]. Vol. 45, Critical Reviews in Microbiology. Taylor and Francis Ltd; 2019 [cited 2020 Sep 28]. p. 131–61. Available from: /pmc/articles/PMC6625916/?report=abstract
Wu C, Wang Y, Shi X, Wang S, Ren H, Shen Z, et al. Rapid rise of the ESBL and mcr-1 genes in Escherichia coli of chicken origin in China, 2008–2014. Emerg Microbes Infect [Internet]. 2018 Dec 1 [cited 2020 Sep 28];7(1):1–10. Available from: https://www.tandfonline.com/doi/full/10.1038/s41426-018-0033-1
Jeannot K, Bolard A, Plésiat P. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 2017 May 1;49(5):526–35.
Liu YY, Chandler CE, Leung LM, McElheny CL, Mettus RT, Shanks RMQ, et al. Structural modification of lipopolysaccharide conferred by mcr-1 in gram-negative ESKAPE pathogens. Antimicrob Agents Chemother [Internet]. 2017 Jun 1 [cited 2020 Sep 28];61(6). Available from: http://aac.asm.org/
Luo Q, Yu W, Zhou K, Guo L, Shen P, Lu H, et al. Molecular Epidemiology and Colistin Resistant Mechanism of mcr-Positive and mcr-Negative Clinical Isolated Escherichia coli. Front Microbiol [Internet]. 2017 Nov 17 [cited 2020 Sep 28];8(NOV):2262. Available from: http://journal.frontiersin.org/article/10.3389/fmicb.2017.02262/full
Doumith M, Godbole G, Ashton P, Larkin L, Dallman T, Day M, et al. Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J Antimicrob Chemother [Internet]. 2016 Aug 1 [cited 2020 Sep 28];71(8):2300–5. Available from: https://academic.oup.com/jac/article/71/8/2300/2237830
Gao R, Hu Y, Li Z, Sun J, Wang Q, Lin J, et al. Dissemination and Mechanism for the MCR-1 Colistin Resistance. Zhang G, editor. PLOS Pathog [Internet]. 2016 Nov 28 [cited 2020 Sep 28];12(11):e1005957. Available from: https://dx.plos.org/10.1371/journal.ppat.1005957
Wang Q, Li Z, Lin J, Wang X, Deng X, Feng Y. Complex dissemination of the diversified mcr-1-harbouring plasmids in Escherichia coli of different sequence types. Oncotarget [Internet]. 2016 Oct 12 [cited 2020 Sep 28];7(50):82112–22. Available from: www.impactjournals.com/oncotarget/
OPS. OMS. Alerta Epidemiológica; Enterobacterias con resistencia transferible a colistina, Implicaciones para la salud publica en las Américas [Internet]. 2016 [cited 2020 Sep 28]. Available from: www.paho.org
Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [Internet]. Vol. 40, Clinical Infectious Diseases. Oxford Academic; 2005 [cited 2020 Sep 28]. p. 1333–41. Available from: https://academic.oup.com/cid/article-lookup/doi/10.1086/429323
Doi Y. Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections. Clin Infect Dis [Internet]. 2019 Nov 13 [cited 2020 Sep 28];69(S7):S565–75. Available from: https://academic.oup.com/cid/article/69/Supplement_7/S565/5623998
WHO. WHO | Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO [Internet]. 2017 [cited 2020 Sep 28]; Available from: http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/ en/
Salud IN de. INFORME DE RESULTADOS DE LA VIGILANCIA POR LABORATORIO DE RESISTENCIA ANTIMICROBIANA EN INFECCIONES ASOCIADAS A LA ATENCIÓN EN SALUD [Internet]. 2018 [cited 2020 Nov 3]. Available from: https://www.ins.gov.co/buscador-eventos/Informacin de laboratorio/Informe-vigilancia-por-laboratorio-resistencia-antimicrobiana-y-whonet-IAAS- 2018.pdf
OMS. Resistencia a los antimicrobianos [Internet]. 2020 [cited 2020 Oct 1]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/resistencia-a-los-antimicrobianos
Rhouma M, Letellier A. Extended-spectrum β-lactamases, carbapenemases and the mcr-1 gene: is there a historical link? Vol. 49, International Journal of Antimicrobial Agents. Elsevier B.V.; 2017. p. 269–71.
OPS O. OPS/OMS | Países de las Américas deben actuar ahora para proteger a las personas de las bacterias resistentes a los antibióticos [Internet]. [cited 2020 Oct 1]. Available from: https://www.paho.org/hq/index.php?option=com_content&view=article&id=9512:2014-co untries-americas-share-risk-antibiotic-resistance-must-act-now-protect-health&Itemid=19 26&lang=es
Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis [Internet]. 2017 Feb 1 [cited 2020 Nov 3];17(2):153–63. Available from: http://www.thelancet.com/article/S1473309916302572/fulltext
Karaiskos I, Lagou S, Pontikis K, Rapti V, Poulakou G. The “Old” and the “New” 52 antibiotics for MDR Gram-negative pathogens: For whom, when, and how. Vol. 7, Frontiers in Public Health. Frontiers Media S.A.; 2019. p. 151.
Poirel L, Jayol A, Nordmanna P. Polymyxins: Antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes [Internet]. Vol. 30, Clinical Microbiology Reviews. American Society for Microbiology; 2017 [cited 2020 Sep 29]. p. 557–96. Available from: http://cmr.asm.org/
Molina J, Cordero E, Palomino J, Pachón J. Aminoglycosides and polymyxins. Enferm Infecc Microbiol Clin [Internet]. 2009 Mar 1 [cited 2020 Sep 29];27(3):178–88. Available from: http://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-artic ulo-aminoglucosidos-polimixinas-S0213005X09000986
Bush K, Bradford PA. β-lactams and β-lactamase inhibitors: An overview. Cold Spring Harb Perspect Med [Internet]. 2016 Aug 1 [cited 2020 Oct 21];6(8). Available from: /pmc/articles/PMC4968164/?report=abstract
Catry B, Cavaleri M, Baptiste K, Grave K, Grein K, Holm A, et al. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health. Vol. 46, International Journal of Antimicrobial Agents. Elsevier B.V.; 2015. p. 297–306.
Mendes Oliveira VR, Paiva MC, Lima WG. Plasmid-mediated colistin resistance in Latin America and Caribbean: A systematic review. Vol. 31, Travel Medicine and Infectious Disease. Elsevier USA; 2019. p. 101459.
Tiwari S, Jamal SB, Hassan SS, Carvalho PVSD, Almeida S, Barh D, et al. Two-Component Signal Transduction Systems of Pathogenic Bacteria As Targets for Antimicrobial Therapy: An Overview. Front Microbiol [Internet]. 2017 Oct 10 [cited 2020 Sep 28];8(OCT):1878. Available from: http://journal.frontiersin.org/article/10.3389/fmicb.2017.01878/full
Kempf I, Fleury MA, Drider D, Bruneau M, Sanders P, Chauvin C, et al. What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe? Vol. 42, International Journal of Antimicrobial Agents. Elsevier; 2013. p. 379–83.
Instituto Colombiano Agropecuario ICA. Resolucion No 00022747 [Internet]. 2018 [cited 2020 Sep 28]. Available from: https://www.ica.gov.co/getattachment/4972ba67-e1ba-4b2a-89ed-09f54f5c62b4/2018R2 2747.aspx
Carattoli A. Plasmids and the spread of resistance. Vol. 303, International Journal of Medical Microbiology. Urban & Fischer; 2013. p. 298–304.
Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005 Dec 1;63(3):219–28.
Cao L, Li X, Xu Y, Shen J. Prevalence and molecular characteristics of <em>mcr-1</em> colistin resistance in <em>Escherichia coli</em>: isolates of clinical infection from a Chinese University Hospital. Infect Drug Resist [Internet]. 2018 Sep 26 [cited 2020 Sep 28];Volume 11:1597–603. Available from: https://www.dovepress.com/prevalence-and-molecular-characteristics-of-mcr-1-colistin-r esistance--peer-reviewed-article-IDR
Mathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high- risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev [Internet]. 2015 Jul 1 [cited 2020 Sep 28];28(3):565–91. Available from: http://cmr.asm.org/
Chaudhuri RR, Henderson IR. The evolution of the Escherichia coli phylogeny [Internet]. Vol. 12, Infection, Genetics and Evolution. Infect Genet Evol; 2012 [cited 2020 Oct 21]. p. 214–26. Available from: https://pubmed.ncbi.nlm.nih.gov/22266241/
Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006 Jun 1;34(5 SUPPL.):S20–8.
Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli st131, an intriguing clonal group. Clin Microbiol Rev [Internet]. 2014 Jul 1 [cited 2020 Sep 28];27(3):543–74. Available from: http://cmr.asm.org/
Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli [Internet]. Vol. 2, Nature Reviews Microbiology. Nature Publishing Group; 2004 [cited 2020 Oct 21]. p. 123–40. Available from: www.nature.com/reviews/micro
Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance [Internet]. Vol. 22, Clinical Microbiology and Infection. Elsevier B.V.; 2016 [cited 2020 Oct 21]. p. 416–22. Available from: https://pubmed.ncbi.nlm.nih.gov/26706614/
Ruiz SJ, Montealegre MC, Ruiz-Garbajosa P, Correa A, Briceño DF, Martinez E, et al. First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J Clin Microbiol [Internet]. 2011 May [cited 2020 Nov 3];49(5):1993–6. Available from: /pmc/articles/PMC3122632/?report=abstract
Cadena ED La, Mojica MF, Castillo N, Correa A, Appel TM, García-Betancur JC, et al. Genomic analysis of ctx-m-group-1-producing extraintestinal pathogenic e. Coli (expec) from patients with urinary tract infections (uti) from colombia. Antibiotics [Internet]. 2020 Dec 1 [cited 2021 Jun 7];9(12):1–9. Available from: https://pubmed.ncbi.nlm.nih.gov/33322118/
Dijkshoorn L, Ursing BM, Ursing JB. Strain, clone and species: Comments on three basic concepts of bacteriology [Internet]. Vol. 49, Journal of Medical Microbiology. Lippincott Williams and Wilkins; 2000 [cited 2020 Nov 3]. p. 397–401. Available from: https://www.microbiologyresearch.org/content/journal/jmm/10.1099/0022-1317-49-5-397
Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance [Internet]. Vol. 35, FEMS Microbiology Reviews. Oxford Academic; 2011 [cited 2020 Nov 3]. p. 736–55. Available from: https://academic.oup.com/femsre/article/35/5/736/2680367
Ortiz de la Tabla V, Ortega A, Buñuel F, Pérez-Vázquez M, Marcos B, Oteo J. Detection of the high-risk clone ST131 of Escherichia coli carrying the colistin resistance gene mcr-1 and causing acute peritonitis. Vol. 49, International Journal of Antimicrobial Agents. Elsevier B.V.; 2017. p. 115–6.
Flament-Simon SC, de Toro M, Mora A, García V, García-Meniño I, Díaz-Jiménez D, et al. Whole Genome Sequencing and Characteristics of mcr-1–Harboring Plasmids of Porcine Escherichia coli Isolates Belonging to the High-Risk Clone O25b:H4-ST131 Clade B. Front Microbiol. 2020 Mar 24;11:387.
Bi Z, Berglund B, Sun Q, Nilsson M, Chen B, Tärnberg M, et al. Prevalence of the mcr-1 colistin resistance gene in extended-spectrum β-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China. Int J Antimicrob Agents. 2017 Apr 1;49(4):493–7.
Petty NK, Zakour NLB, Stanton-Cook M, Skippington E, Totsika M, Forde BM, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A [Internet]. 2014 Apr 15 [cited 2020 Oct 3];111(15):5694–9. Available from: /pmc/articles/PMC3992628/?report=abstract
Peirano G, Bradford PA, Kazmierczak KM, Badal RE, Hackel M, Hoban DJ, et al. Global Incidence of Carbapenemase-Producing Escherichia Coli ST131. Emerg Infect Dis [Internet]. 2014 Nov 1 [cited 2020 Oct 2];20(11):1928–31. Available from: https://wwwnc.cdc.gov/eid/article/20/11/14-1388_article
Simner PJ, Bergman Y, Trejo M, Roberts AA, Marayan R, Tekle T, et al. Two-site evaluation of the colistin broth disk elution test to determine colistin in vitro activity against Gram-negative bacilli. J Clin Microbiol [Internet]. 2019 Feb 1 [cited 2020 Sep 28];57(2). Available from: https://doi.org/10.1128/JCM
Clinical and Laboratory Standards Institute CLSI [Internet]. [cited 2020 Nov 3]. Available from: https://clsi.org/standards/products/free-resources/access-our-free-resources/
Clermont O, Bonacorsi S, Bingen E. Rapid and Simple Determination of the Escherichia coli Phylogenetic Group. Appl Environ Microbiol [Internet]. 2000 [cited 2021 Aug 22];66(10):4555. Available from: /pmc/articles/PMC92342
Larsen M V., Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012 Apr;50(4):1355–61.
Joensen KG, Tetzschner AMM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J Clin Microbiol. 2015 Aug 1;53(8):2410–26
Carattoli A, Zankari E, García-Fernández A, Larsen MV, Lund O, Villa L, et al. In Silico Detection and Typing of Plasmids using PlasmidFinder and Plasmid Multilocus Sequence Typing. 2014 [cited 2021 Aug 31]; Available from: http://cge.cbs.dtu.dk/services/PlasmidFinder/
Tetzschner AMM, Johnson JR, Johnston BD, Lund O, Scheutz F. In Silico genotyping of Escherichia coli isolates for extraintestinal virulence genes by use of whole-genome sequencing data. J Clin Microbiol. 2020 Oct 1;58(10).
Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother [Internet]. 2020 Dec 1 [cited 2021 Aug 31];75(12):3491. Available from: /pmc/articles/PMC7662176/
Brettin T, Davis JJ, Disz T, Edwards RA, Gerdes S, Olsen GJ, et al. RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci Rep [Internet]. 2015 Feb 10 [cited 2021 Aug 31];5. Available from: /pmc/articles/PMC4322359/
Fenwick AJ, Bergman Y, Lewis S, Yee R, Uhlemann A-C, Cole N, et al. Evaluation of the NG-Test MCR-1 Lateral Flow Assay and EDTA-Colistin Broth Disk Elution Methods To Detect Plasmid-Mediated Colistin Resistance among Gram-Negative Bacterial Isolates. J Clin Microbiol [Internet]. 2020 [cited 2021 Aug 22];58(4). Available from: /pmc/articles/PMC7098752/
INVIMA. ALERTA SANITARIA OFICINA DE LABORATORIOS Y CONTROL DE CALIDAD-LABORATORIO MICROBIOLOGÍA DE ALIMENTOS. [cited 2021 Aug 22]; Available from: http://dx.doi.org/10.1016/S1473-3099
Rada AM, de la Cadena E, Agudelo C, Capataz C, Orozco N, Pallares C, et al. Dynamics of blaKPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity. Antimicrob Agents Chemother [Internet]. 2020 Dec 1 [cited 2021 Aug 31];64(12). Available from: https://journals.asm.org/journal/aac
Ruiz SJ, Montealegre MC, Ruiz-Garbajosa P, Correa A, Briceño DF, Martinez E, et al. First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J Clin Microbiol [Internet]. 2011 May [cited 2021 Sep 1];49(5):1993–6. Available from: https://journals.asm.org/journal/jcm
Lopes R, Furlan JPR, dos Santos LDR, Gallo IFL, Stehling EG. Colistin-Resistant mcr-1-Positive Escherichia coli ST131-H22 Carrying blaCTX–M–15 and qnrB19 in Agricultural Soil. Front Microbiol. 2021 Apr 9;0:753.
MG W, MA E, DF S, GG S, KM K. Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program. PLoS One [Internet]. 2018 Apr 1 [cited 2021 Sep 1];13(4). Available from: https://pubmed.ncbi.nlm.nih.gov/29608599/
dc.rights.spa.fl_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_14cb
rights_invalid_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
https://creativecommons.org/licenses/by-nc-sa/4.0/
Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
dc.format.extent.spa.fl_str_mv 57p.
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad Colegio Mayor de Cundinamarca
dc.publisher.faculty.spa.fl_str_mv Facultad de Ciencias de la Salud
dc.publisher.place.spa.fl_str_mv Bogotá
dc.publisher.program.spa.fl_str_mv Bacteriología y Laboratorio Clínico
institution Colegio Mayor de Cundinamarca
bitstream.url.fl_str_mv https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/9/FORMATO%20CARTA%20DERECHOS%20DE%20AUTOR%20FIRMA%20DECANA%20IIP2021%20Mahecha.docx.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/11/PORTADA%20TRABAJOS%20DE%20GRADO%20IIP%202021%20Mahecha%20Lopez.docx%281%29.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/13/FORMATO%20DERECHOS%20DE%20AUTOR%20TG%202021-Mahecha%20Velandia.doc.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/15/Caracterizaci%c3%b3n%20molecular%20de%20genes%20de%20resistencia%20mcr-1%20en%20aislamientos%20de%20E.%20coli%20resistentes%20a%20colistina%20de%20instituciones%20de%20tercer%20nivel%20en%20Colombia.docx.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/18/CARTA%20DECANO%20DERECHOS%20DE%20AUTOR%20MODALIDADES%20DE%20GRADO%20IIP%202021.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/7/license.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/19/Caracterizaci%c3%b3n%20molecular%20de%20genes%20de%20resistencia%20mcr-1%20en%20aislamientos%20de%20E.%20coli%20resistentes%20a%20colistina%20de%20instituciones%20de%20tercer%20nivel%20en%20Colombia.docx.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/20/Trabajo%20de%20Grado%20Mahecha%20Lopez.pptx
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/21/FORMATO%20CARTA%20DERECHOS%20DE%20AUTOR%20FIRMA%20DECANA%20IIP2021%20Mahecha.docx.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/22/FORMATO%20DERECHOS%20DE%20AUTOR%20TG%202021-Mahecha%20Velandia.doc.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/23/Caracterizaci%c3%b3n%20molecular%20de%20genes%20de%20resistencia%20mcr-1%20en%20aislamientos%20de%20E.%20coli%20resistentes%20a%20colistina%20de%20instituciones%20de%20tercer%20nivel%20en%20Colombia.docx.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/24/Trabajo%20de%20Grado%20Mahecha%20Lopez.pptx.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/25/FORMATO%20CARTA%20DERECHOS%20DE%20AUTOR%20FIRMA%20DECANA%20IIP2021%20Mahecha.docx.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/26/FORMATO%20DERECHOS%20DE%20AUTOR%20TG%202021-Mahecha%20Velandia.doc.pdf.txt
bitstream.checksum.fl_str_mv 0bf388f63ba0609fb96321c12ee3d4da
4cba4dd039fd584c79795301c8a75dfa
78d346233ce80f4e6b3697b596517691
7b62d4579615b490302dbaa41188ac4c
a0b679346419d6b2cfdc9d604a17cf4a
2f9959eaf5b71fae44bbf9ec84150c7a
53fe3a9427867961da787ecec2a0c3f9
076b58b3ecf916947adc7b8ba3c3c8c9
4ecf4e31fe7bc2028ef6227af8133010
32fed26df0ebea84362da481c1b3aef3
fc1a3ed404dedba395f69fc2c76bc8c0
823b2863707fc796aa37bc2f12979a9e
23d3d0e973cc2e04d63d5aed77e2c4b1
6f65baf8b6cce6ce423c1a8e5891fb09
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital Unicolmayor
repository.mail.fl_str_mv repositorio@unicolmayor.edu.co
_version_ 1807009117397581824
spelling Pinilla Bermúdez, Gladys428561c7b44bd4a7c33f25d8f79d473cDe La Cadena Vivas, Elsa Piedad350a12abe46b2be450e858b2cea86416Mahecha López, Mateo63ddf5fc918b5e3464083f0ffc184017Velandia López, Ana María252b4e24e6d1fa7f7116337fc73cf7bd2022-05-11T00:27:05Z2022-05-11T00:27:05Z2021-09-03https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5552La resistencia bacteriana es un problema de carácter mundial que pone en riesgo la salud humana y agota las opciones terapéuticas contra bacterias patógenas multiresistentes a los antibióticos. La resistencia a la colistina estaba asociada a mutaciones cromosomales, sin embargo, en el año 2015 reportaron por primera vez el gen mcr-1 que genera resistencia a polimixinas a través de plásmidos. Después de este, se han realizado reportes prácticamente por todo el mundo, asociados tanto a aislamientos de origen animal como humanos. En Colombia fue detectado por primera vez en el año 2016 en tres aislamientos de Salmonella entérica serovar Typhimurium y un aislamiento de E. coli. En esta investigación se estudiaron 32 aislados de E. coli recolectados de instituciones hospitalarias de tercer nivel en Colombia con el objetivo de determinar las características genéticas y fenotipicas de resistencia.De los 32 aislamientos estudiados, se confirmaron 7 como resistentes a colistina por metodología CBDE. La PCR mostro que 5 de los 7 aislados portaban genes mcr-1,uno de estos con fenotipo BLEE resistente a ceftriaxona, cefotaxime y susceptibilidad reducida a ceftazidime y confirmación de CTXM-55 por SGC.Dos aislamientos presentaron clonalidad del 100% por PFGE, la mayoria de aislados con grupo filogenético B1 y dos compartiendo el mismo MLST, se detectaron distintos plasmidos con predominio IncFII y dentro de su entorno genético se pudo identificar un aislado portando mcr-1 posiblemente en un plasmido tipo Incl.1. Planteamiento del problema 8 2. Objetivos 9 2.1 Objetivo general 9 2.2 Objetivos específicos 9 3. Justificación 10 4. Marco teórico 12 4.1 Antecedentes 12 4.2 Bases teóricas 21 4.2.1 Resistencia bacteriana 21 4.2.2 Polimixinas 23 4.2.3 Mecanismos de resistencia a polimixinas 24 4.2.4 Detección de genes mcr-1 implicados en la resistencia a polimixinas 25 4.2.5 Plásmidos implicados en la diseminación de genes mcr-1 26 4.2.6 Escherichia coli 27 4.2.7 Clones de alto riesgo 28 4.2.8 Relación entre genes mcr-1 y otros genes de resistencia 29 4.2.9. Multilocus sequence typing (MLST) 30 4.2.10 Métodos para evaluar la susceptibilidad a polimixinas 31 4.3 Marco legal 32 5. Diseño metodológico 33 5.1 Tipo de investigación 33 5.2 Impacto de la investigación 33 5.3 Población y criterios de inclusión 33 5.4 Técnicas y procedimientos 34 5.4.1 Pruebas de susceptibilidad antimicrobiana 34 5.4.2 Identificación molecular de genes mcr-1 y otros genes de resistencia 37 5.4.3 Electroforesis de Campos Pulsados (PFGE) para estudio de clonalidad molecular 38 5.4.4 Secuenciación de Genoma Completo 38 5.4.5 Análisis de bioinformática 39 5.4.6 Plan de análisis de datos 40 6. Resultados 40 6.1 Confirmación de resistencia a colistina 40 6.2 Detección de genes mcr-1 42 6.3 Análisis fenotípico de susceptibilidad antibiótica 43 6.4 Análisis de clonalidad 43 6.5 Análisis de secuencias de genoma completo 44 6.5.1 Genes de virulencia 45 6.5.2 Plásmidos de incompatibilidad 45 6.5.3 Resistoma 46 6.5.4 Entorno genético de mcr-1 47 7. Discusión 47 8. Conclusiones 51 9. Referencias bibliográficas 52PregradoBacteriólogo(a) y Laboratorista Clínico57p.application/pdfspaUniversidad Colegio Mayor de CundinamarcaFacultad de Ciencias de la SaludBogotáBacteriología y Laboratorio ClínicoDerechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/closedAccessAtribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)http://purl.org/coar/access_right/c_14cbCaracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en ColombiaTrabajo de grado - Pregradohttp://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/version/c_970fb48d4fbd8a85Textinfo:eu-repo/semantics/bachelorThesishttps://purl.org/redcol/resource_type/TPinfo:eu-repo/semantics/publishedVersionLiu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect Dis [Internet]. 2016 Feb 1 [cited 2020 Sep 28];16(2):161–8. Available from: http://www.thelancet.com/article/S1473309915004247/fulltextSaavedra SY, Diaz L, Wiesner M, Correa A, Alejandra Arévalo S, Reyes J, et al. Genomic and molecular characterization of clinical isolates of Enterobacteriaceae harboring mcr-1 in Colombia, 2002 to 2016. Antimicrob Agents Chemother [Internet]. 2017 Dec 1 [cited 2020 Sep 28];61(12). Available from: http://aac.asm.org/Velasco JMS, Valderama MTG, Margulieux KR, Diones PCS, Reyes AMB, Leonardia SG, et al. First report of the mcr-1 colistin resistance gene identified in two Escherichia coli isolates from clinical samples, Philippines, 2018. J Glob Antimicrob Resist. 2020 Jun 1;21:291–3.Amin MB, Sraboni AS, Hossain MI, Roy S, Mozmader TAU, Unicomb L, et al. Occurrence and genetic characteristics of mcr-1-positive colistin-resistant E. coli from poultry environments in Bangladesh. J Glob Antimicrob Resist. 2020 Sep 1;22:546–52.Vounba P, Rhouma M, Arsenault J, Bada Alambédji R, Fravalo P, Fairbrother JM. Prevalence of colistin resistance and mcr-1/mcr-2 genes in extended-spectrum β-lactamase/AmpC-producing Escherichia coli isolated from chickens in Canada, Senegal and Vietnam. J Glob Antimicrob Resist. 2019 Dec 1;19:222–7.Zhang H, Srinivas S, Xu Y, Wei W, Feng Y. Genetic and Biochemical Mechanisms for Bacterial Lipid A Modifiers Associated with Polymyxin Resistance [Internet]. Vol. 44, Trends in Biochemical Sciences. Elsevier Ltd; 2019 [cited 2020 Sep 28]. p. 973–88. Available from: http://www.cell.com/article/S0968000419301355/fulltextEzadi F, Ardebili A, Mirnejad R. Antimicrobial susceptibility testing for polymyxins: Challenges, issues, and recommendations [Internet]. Vol. 57, Journal of Clinical Microbiology. American Society for Microbiology; 2018 [cited 2020 Sep 28]. Available from: https://jcm.asm.org/content/57/4/e01390-18Bell DT, Bergman Y, Kazmi AQ, Lewis S, Tamma PD, Simner PJ. A novel phenotypic method to screen for plasmid-mediated colistin resistance among enterobacteriales. J Clin Microbiol [Internet]. 2019 May 1 [cited 2020 Sep 28];57(5). Available from: https://doi.org/10.1128/JCM.00040-19.Lerminiaux NA, Cameron ADS. Horizontal transfer of antibiotic resistance genes in clinical environments. Can J Microbiol [Internet]. 2019 Jan [cited 2020 Sep 28];65(1):34–44. Available from: http://www.nrcresearchpress.com/doi/10.1139/cjm-2018-0275Tarabai H, Valcek A, Jamborova I, Vazhov S V., Karyakin I V., Raab R, et al. Plasmid-mediated mcr-1 colistin resistance in Escherichia coli from a black kite in Russia. Antimicrob Agents Chemother [Internet]. 2019 Sep 1 [cited 2020 Sep 28];63(9). Available from: https://doi.org/10.1128/AACNang SC, Li J, Velkov T. The rise and spread of mcr plasmid-mediated polymyxin resistance [Internet]. Vol. 45, Critical Reviews in Microbiology. Taylor and Francis Ltd; 2019 [cited 2020 Sep 28]. p. 131–61. Available from: /pmc/articles/PMC6625916/?report=abstractWu C, Wang Y, Shi X, Wang S, Ren H, Shen Z, et al. Rapid rise of the ESBL and mcr-1 genes in Escherichia coli of chicken origin in China, 2008–2014. Emerg Microbes Infect [Internet]. 2018 Dec 1 [cited 2020 Sep 28];7(1):1–10. Available from: https://www.tandfonline.com/doi/full/10.1038/s41426-018-0033-1Jeannot K, Bolard A, Plésiat P. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 2017 May 1;49(5):526–35.Liu YY, Chandler CE, Leung LM, McElheny CL, Mettus RT, Shanks RMQ, et al. Structural modification of lipopolysaccharide conferred by mcr-1 in gram-negative ESKAPE pathogens. Antimicrob Agents Chemother [Internet]. 2017 Jun 1 [cited 2020 Sep 28];61(6). Available from: http://aac.asm.org/Luo Q, Yu W, Zhou K, Guo L, Shen P, Lu H, et al. Molecular Epidemiology and Colistin Resistant Mechanism of mcr-Positive and mcr-Negative Clinical Isolated Escherichia coli. Front Microbiol [Internet]. 2017 Nov 17 [cited 2020 Sep 28];8(NOV):2262. Available from: http://journal.frontiersin.org/article/10.3389/fmicb.2017.02262/fullDoumith M, Godbole G, Ashton P, Larkin L, Dallman T, Day M, et al. Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J Antimicrob Chemother [Internet]. 2016 Aug 1 [cited 2020 Sep 28];71(8):2300–5. Available from: https://academic.oup.com/jac/article/71/8/2300/2237830Gao R, Hu Y, Li Z, Sun J, Wang Q, Lin J, et al. Dissemination and Mechanism for the MCR-1 Colistin Resistance. Zhang G, editor. PLOS Pathog [Internet]. 2016 Nov 28 [cited 2020 Sep 28];12(11):e1005957. Available from: https://dx.plos.org/10.1371/journal.ppat.1005957Wang Q, Li Z, Lin J, Wang X, Deng X, Feng Y. Complex dissemination of the diversified mcr-1-harbouring plasmids in Escherichia coli of different sequence types. Oncotarget [Internet]. 2016 Oct 12 [cited 2020 Sep 28];7(50):82112–22. Available from: www.impactjournals.com/oncotarget/OPS. OMS. Alerta Epidemiológica; Enterobacterias con resistencia transferible a colistina, Implicaciones para la salud publica en las Américas [Internet]. 2016 [cited 2020 Sep 28]. Available from: www.paho.orgFalagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [Internet]. Vol. 40, Clinical Infectious Diseases. Oxford Academic; 2005 [cited 2020 Sep 28]. p. 1333–41. Available from: https://academic.oup.com/cid/article-lookup/doi/10.1086/429323Doi Y. Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections. Clin Infect Dis [Internet]. 2019 Nov 13 [cited 2020 Sep 28];69(S7):S565–75. Available from: https://academic.oup.com/cid/article/69/Supplement_7/S565/5623998WHO. WHO | Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO [Internet]. 2017 [cited 2020 Sep 28]; Available from: http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/ en/Salud IN de. INFORME DE RESULTADOS DE LA VIGILANCIA POR LABORATORIO DE RESISTENCIA ANTIMICROBIANA EN INFECCIONES ASOCIADAS A LA ATENCIÓN EN SALUD [Internet]. 2018 [cited 2020 Nov 3]. Available from: https://www.ins.gov.co/buscador-eventos/Informacin de laboratorio/Informe-vigilancia-por-laboratorio-resistencia-antimicrobiana-y-whonet-IAAS- 2018.pdfOMS. Resistencia a los antimicrobianos [Internet]. 2020 [cited 2020 Oct 1]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/resistencia-a-los-antimicrobianosRhouma M, Letellier A. Extended-spectrum β-lactamases, carbapenemases and the mcr-1 gene: is there a historical link? Vol. 49, International Journal of Antimicrobial Agents. Elsevier B.V.; 2017. p. 269–71.OPS O. OPS/OMS | Países de las Américas deben actuar ahora para proteger a las personas de las bacterias resistentes a los antibióticos [Internet]. [cited 2020 Oct 1]. Available from: https://www.paho.org/hq/index.php?option=com_content&view=article&id=9512:2014-co untries-americas-share-risk-antibiotic-resistance-must-act-now-protect-health&Itemid=19 26&lang=esGrundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis [Internet]. 2017 Feb 1 [cited 2020 Nov 3];17(2):153–63. Available from: http://www.thelancet.com/article/S1473309916302572/fulltextKaraiskos I, Lagou S, Pontikis K, Rapti V, Poulakou G. The “Old” and the “New” 52 antibiotics for MDR Gram-negative pathogens: For whom, when, and how. Vol. 7, Frontiers in Public Health. Frontiers Media S.A.; 2019. p. 151.Poirel L, Jayol A, Nordmanna P. Polymyxins: Antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes [Internet]. Vol. 30, Clinical Microbiology Reviews. American Society for Microbiology; 2017 [cited 2020 Sep 29]. p. 557–96. Available from: http://cmr.asm.org/Molina J, Cordero E, Palomino J, Pachón J. Aminoglycosides and polymyxins. Enferm Infecc Microbiol Clin [Internet]. 2009 Mar 1 [cited 2020 Sep 29];27(3):178–88. Available from: http://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-artic ulo-aminoglucosidos-polimixinas-S0213005X09000986Bush K, Bradford PA. β-lactams and β-lactamase inhibitors: An overview. Cold Spring Harb Perspect Med [Internet]. 2016 Aug 1 [cited 2020 Oct 21];6(8). Available from: /pmc/articles/PMC4968164/?report=abstractCatry B, Cavaleri M, Baptiste K, Grave K, Grein K, Holm A, et al. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health. Vol. 46, International Journal of Antimicrobial Agents. Elsevier B.V.; 2015. p. 297–306.Mendes Oliveira VR, Paiva MC, Lima WG. Plasmid-mediated colistin resistance in Latin America and Caribbean: A systematic review. Vol. 31, Travel Medicine and Infectious Disease. Elsevier USA; 2019. p. 101459.Tiwari S, Jamal SB, Hassan SS, Carvalho PVSD, Almeida S, Barh D, et al. Two-Component Signal Transduction Systems of Pathogenic Bacteria As Targets for Antimicrobial Therapy: An Overview. Front Microbiol [Internet]. 2017 Oct 10 [cited 2020 Sep 28];8(OCT):1878. Available from: http://journal.frontiersin.org/article/10.3389/fmicb.2017.01878/fullKempf I, Fleury MA, Drider D, Bruneau M, Sanders P, Chauvin C, et al. What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe? Vol. 42, International Journal of Antimicrobial Agents. Elsevier; 2013. p. 379–83.Instituto Colombiano Agropecuario ICA. Resolucion No 00022747 [Internet]. 2018 [cited 2020 Sep 28]. Available from: https://www.ica.gov.co/getattachment/4972ba67-e1ba-4b2a-89ed-09f54f5c62b4/2018R2 2747.aspxCarattoli A. Plasmids and the spread of resistance. Vol. 303, International Journal of Medical Microbiology. Urban & Fischer; 2013. p. 298–304.Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005 Dec 1;63(3):219–28.Cao L, Li X, Xu Y, Shen J. Prevalence and molecular characteristics of <em>mcr-1</em> colistin resistance in <em>Escherichia coli</em>: isolates of clinical infection from a Chinese University Hospital. Infect Drug Resist [Internet]. 2018 Sep 26 [cited 2020 Sep 28];Volume 11:1597–603. Available from: https://www.dovepress.com/prevalence-and-molecular-characteristics-of-mcr-1-colistin-r esistance--peer-reviewed-article-IDRMathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high- risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev [Internet]. 2015 Jul 1 [cited 2020 Sep 28];28(3):565–91. Available from: http://cmr.asm.org/Chaudhuri RR, Henderson IR. The evolution of the Escherichia coli phylogeny [Internet]. Vol. 12, Infection, Genetics and Evolution. Infect Genet Evol; 2012 [cited 2020 Oct 21]. p. 214–26. Available from: https://pubmed.ncbi.nlm.nih.gov/22266241/Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006 Jun 1;34(5 SUPPL.):S20–8.Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli st131, an intriguing clonal group. Clin Microbiol Rev [Internet]. 2014 Jul 1 [cited 2020 Sep 28];27(3):543–74. Available from: http://cmr.asm.org/Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli [Internet]. Vol. 2, Nature Reviews Microbiology. Nature Publishing Group; 2004 [cited 2020 Oct 21]. p. 123–40. Available from: www.nature.com/reviews/microFriedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance [Internet]. Vol. 22, Clinical Microbiology and Infection. Elsevier B.V.; 2016 [cited 2020 Oct 21]. p. 416–22. Available from: https://pubmed.ncbi.nlm.nih.gov/26706614/Ruiz SJ, Montealegre MC, Ruiz-Garbajosa P, Correa A, Briceño DF, Martinez E, et al. First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J Clin Microbiol [Internet]. 2011 May [cited 2020 Nov 3];49(5):1993–6. Available from: /pmc/articles/PMC3122632/?report=abstractCadena ED La, Mojica MF, Castillo N, Correa A, Appel TM, García-Betancur JC, et al. Genomic analysis of ctx-m-group-1-producing extraintestinal pathogenic e. Coli (expec) from patients with urinary tract infections (uti) from colombia. Antibiotics [Internet]. 2020 Dec 1 [cited 2021 Jun 7];9(12):1–9. Available from: https://pubmed.ncbi.nlm.nih.gov/33322118/Dijkshoorn L, Ursing BM, Ursing JB. Strain, clone and species: Comments on three basic concepts of bacteriology [Internet]. Vol. 49, Journal of Medical Microbiology. Lippincott Williams and Wilkins; 2000 [cited 2020 Nov 3]. p. 397–401. Available from: https://www.microbiologyresearch.org/content/journal/jmm/10.1099/0022-1317-49-5-397Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance [Internet]. Vol. 35, FEMS Microbiology Reviews. Oxford Academic; 2011 [cited 2020 Nov 3]. p. 736–55. Available from: https://academic.oup.com/femsre/article/35/5/736/2680367Ortiz de la Tabla V, Ortega A, Buñuel F, Pérez-Vázquez M, Marcos B, Oteo J. Detection of the high-risk clone ST131 of Escherichia coli carrying the colistin resistance gene mcr-1 and causing acute peritonitis. Vol. 49, International Journal of Antimicrobial Agents. Elsevier B.V.; 2017. p. 115–6.Flament-Simon SC, de Toro M, Mora A, García V, García-Meniño I, Díaz-Jiménez D, et al. Whole Genome Sequencing and Characteristics of mcr-1–Harboring Plasmids of Porcine Escherichia coli Isolates Belonging to the High-Risk Clone O25b:H4-ST131 Clade B. Front Microbiol. 2020 Mar 24;11:387.Bi Z, Berglund B, Sun Q, Nilsson M, Chen B, Tärnberg M, et al. Prevalence of the mcr-1 colistin resistance gene in extended-spectrum β-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China. Int J Antimicrob Agents. 2017 Apr 1;49(4):493–7.Petty NK, Zakour NLB, Stanton-Cook M, Skippington E, Totsika M, Forde BM, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A [Internet]. 2014 Apr 15 [cited 2020 Oct 3];111(15):5694–9. Available from: /pmc/articles/PMC3992628/?report=abstractPeirano G, Bradford PA, Kazmierczak KM, Badal RE, Hackel M, Hoban DJ, et al. Global Incidence of Carbapenemase-Producing Escherichia Coli ST131. Emerg Infect Dis [Internet]. 2014 Nov 1 [cited 2020 Oct 2];20(11):1928–31. Available from: https://wwwnc.cdc.gov/eid/article/20/11/14-1388_articleSimner PJ, Bergman Y, Trejo M, Roberts AA, Marayan R, Tekle T, et al. Two-site evaluation of the colistin broth disk elution test to determine colistin in vitro activity against Gram-negative bacilli. J Clin Microbiol [Internet]. 2019 Feb 1 [cited 2020 Sep 28];57(2). Available from: https://doi.org/10.1128/JCMClinical and Laboratory Standards Institute CLSI [Internet]. [cited 2020 Nov 3]. Available from: https://clsi.org/standards/products/free-resources/access-our-free-resources/Clermont O, Bonacorsi S, Bingen E. Rapid and Simple Determination of the Escherichia coli Phylogenetic Group. Appl Environ Microbiol [Internet]. 2000 [cited 2021 Aug 22];66(10):4555. Available from: /pmc/articles/PMC92342Larsen M V., Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012 Apr;50(4):1355–61.Joensen KG, Tetzschner AMM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J Clin Microbiol. 2015 Aug 1;53(8):2410–26Carattoli A, Zankari E, García-Fernández A, Larsen MV, Lund O, Villa L, et al. In Silico Detection and Typing of Plasmids using PlasmidFinder and Plasmid Multilocus Sequence Typing. 2014 [cited 2021 Aug 31]; Available from: http://cge.cbs.dtu.dk/services/PlasmidFinder/Tetzschner AMM, Johnson JR, Johnston BD, Lund O, Scheutz F. In Silico genotyping of Escherichia coli isolates for extraintestinal virulence genes by use of whole-genome sequencing data. J Clin Microbiol. 2020 Oct 1;58(10).Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother [Internet]. 2020 Dec 1 [cited 2021 Aug 31];75(12):3491. Available from: /pmc/articles/PMC7662176/Brettin T, Davis JJ, Disz T, Edwards RA, Gerdes S, Olsen GJ, et al. RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci Rep [Internet]. 2015 Feb 10 [cited 2021 Aug 31];5. Available from: /pmc/articles/PMC4322359/Fenwick AJ, Bergman Y, Lewis S, Yee R, Uhlemann A-C, Cole N, et al. Evaluation of the NG-Test MCR-1 Lateral Flow Assay and EDTA-Colistin Broth Disk Elution Methods To Detect Plasmid-Mediated Colistin Resistance among Gram-Negative Bacterial Isolates. J Clin Microbiol [Internet]. 2020 [cited 2021 Aug 22];58(4). Available from: /pmc/articles/PMC7098752/INVIMA. ALERTA SANITARIA OFICINA DE LABORATORIOS Y CONTROL DE CALIDAD-LABORATORIO MICROBIOLOGÍA DE ALIMENTOS. [cited 2021 Aug 22]; Available from: http://dx.doi.org/10.1016/S1473-3099Rada AM, de la Cadena E, Agudelo C, Capataz C, Orozco N, Pallares C, et al. Dynamics of blaKPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity. Antimicrob Agents Chemother [Internet]. 2020 Dec 1 [cited 2021 Aug 31];64(12). Available from: https://journals.asm.org/journal/aacRuiz SJ, Montealegre MC, Ruiz-Garbajosa P, Correa A, Briceño DF, Martinez E, et al. First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J Clin Microbiol [Internet]. 2011 May [cited 2021 Sep 1];49(5):1993–6. Available from: https://journals.asm.org/journal/jcmLopes R, Furlan JPR, dos Santos LDR, Gallo IFL, Stehling EG. Colistin-Resistant mcr-1-Positive Escherichia coli ST131-H22 Carrying blaCTX–M–15 and qnrB19 in Agricultural Soil. Front Microbiol. 2021 Apr 9;0:753.MG W, MA E, DF S, GG S, KM K. Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program. PLoS One [Internet]. 2018 Apr 1 [cited 2021 Sep 1];13(4). Available from: https://pubmed.ncbi.nlm.nih.gov/29608599/Resistencia bacterianaE. coliColistinamcr-1THUMBNAILFORMATO CARTA DERECHOS DE AUTOR FIRMA DECANA IIP2021 Mahecha.docx.pdf.jpgFORMATO CARTA DERECHOS DE AUTOR FIRMA DECANA IIP2021 Mahecha.docx.pdf.jpgGenerated Thumbnailimage/jpeg9663https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/9/FORMATO%20CARTA%20DERECHOS%20DE%20AUTOR%20FIRMA%20DECANA%20IIP2021%20Mahecha.docx.pdf.jpg0bf388f63ba0609fb96321c12ee3d4daMD59metadata only accessPORTADA TRABAJOS DE GRADO IIP 2021 Mahecha Lopez.docx(1).pdf.jpgPORTADA TRABAJOS DE GRADO IIP 2021 Mahecha Lopez.docx(1).pdf.jpgGenerated Thumbnailimage/jpeg8283https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/11/PORTADA%20TRABAJOS%20DE%20GRADO%20IIP%202021%20Mahecha%20Lopez.docx%281%29.pdf.jpg4cba4dd039fd584c79795301c8a75dfaMD511metadata only accessFORMATO DERECHOS DE AUTOR TG 2021-Mahecha Velandia.doc.pdf.jpgFORMATO DERECHOS DE AUTOR TG 2021-Mahecha Velandia.doc.pdf.jpgGenerated Thumbnailimage/jpeg12181https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/13/FORMATO%20DERECHOS%20DE%20AUTOR%20TG%202021-Mahecha%20Velandia.doc.pdf.jpg78d346233ce80f4e6b3697b596517691MD513metadata only accessCaracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia.docx.pdf.jpgCaracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia.docx.pdf.jpgGenerated Thumbnailimage/jpeg6150https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/15/Caracterizaci%c3%b3n%20molecular%20de%20genes%20de%20resistencia%20mcr-1%20en%20aislamientos%20de%20E.%20coli%20resistentes%20a%20colistina%20de%20instituciones%20de%20tercer%20nivel%20en%20Colombia.docx.pdf.jpg7b62d4579615b490302dbaa41188ac4cMD515open accessCARTA DECANO DERECHOS DE AUTOR MODALIDADES DE GRADO IIP 2021.pdf.jpgCARTA DECANO DERECHOS DE AUTOR MODALIDADES DE GRADO IIP 2021.pdf.jpgGenerated Thumbnailimage/jpeg9846https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/18/CARTA%20DECANO%20DERECHOS%20DE%20AUTOR%20MODALIDADES%20DE%20GRADO%20IIP%202021.pdf.jpga0b679346419d6b2cfdc9d604a17cf4aMD518metadata only accessLICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/7/license.txt2f9959eaf5b71fae44bbf9ec84150c7aMD57open accessORIGINALCaracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia.docx.pdfCaracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia.docx.pdfapplication/pdf1054681https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/19/Caracterizaci%c3%b3n%20molecular%20de%20genes%20de%20resistencia%20mcr-1%20en%20aislamientos%20de%20E.%20coli%20resistentes%20a%20colistina%20de%20instituciones%20de%20tercer%20nivel%20en%20Colombia.docx.pdf53fe3a9427867961da787ecec2a0c3f9MD519open accessTrabajo de Grado Mahecha Lopez.pptxTrabajo de Grado Mahecha Lopez.pptxapplication/vnd.openxmlformats-officedocument.presentationml.presentation9276751https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/20/Trabajo%20de%20Grado%20Mahecha%20Lopez.pptx076b58b3ecf916947adc7b8ba3c3c8c9MD520open accessFORMATO CARTA DERECHOS DE AUTOR FIRMA DECANA IIP2021 Mahecha.docx.pdfFORMATO CARTA DERECHOS DE AUTOR FIRMA DECANA IIP2021 Mahecha.docx.pdfapplication/pdf99279https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/21/FORMATO%20CARTA%20DERECHOS%20DE%20AUTOR%20FIRMA%20DECANA%20IIP2021%20Mahecha.docx.pdf4ecf4e31fe7bc2028ef6227af8133010MD521metadata only accessFORMATO DERECHOS DE AUTOR TG 2021-Mahecha Velandia.doc.pdfFORMATO DERECHOS DE AUTOR TG 2021-Mahecha Velandia.doc.pdfapplication/pdf339363https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/22/FORMATO%20DERECHOS%20DE%20AUTOR%20TG%202021-Mahecha%20Velandia.doc.pdf32fed26df0ebea84362da481c1b3aef3MD522metadata only accessTEXTCaracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia.docx.pdf.txtCaracterización molecular de genes de resistencia mcr-1 en aislamientos de E. coli resistentes a colistina de instituciones de tercer nivel en Colombia.docx.pdf.txtExtracted texttext/plain100298https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/23/Caracterizaci%c3%b3n%20molecular%20de%20genes%20de%20resistencia%20mcr-1%20en%20aislamientos%20de%20E.%20coli%20resistentes%20a%20colistina%20de%20instituciones%20de%20tercer%20nivel%20en%20Colombia.docx.pdf.txtfc1a3ed404dedba395f69fc2c76bc8c0MD523open accessTrabajo de Grado Mahecha Lopez.pptx.txtTrabajo de Grado Mahecha Lopez.pptx.txtExtracted texttext/plain10529https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/24/Trabajo%20de%20Grado%20Mahecha%20Lopez.pptx.txt823b2863707fc796aa37bc2f12979a9eMD524open accessFORMATO CARTA DERECHOS DE AUTOR FIRMA DECANA IIP2021 Mahecha.docx.pdf.txtFORMATO CARTA DERECHOS DE AUTOR FIRMA DECANA IIP2021 Mahecha.docx.pdf.txtExtracted texttext/plain1113https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/25/FORMATO%20CARTA%20DERECHOS%20DE%20AUTOR%20FIRMA%20DECANA%20IIP2021%20Mahecha.docx.pdf.txt23d3d0e973cc2e04d63d5aed77e2c4b1MD525metadata only accessFORMATO DERECHOS DE AUTOR TG 2021-Mahecha Velandia.doc.pdf.txtFORMATO DERECHOS DE AUTOR TG 2021-Mahecha Velandia.doc.pdf.txtExtracted texttext/plain1003https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/5552/26/FORMATO%20DERECHOS%20DE%20AUTOR%20TG%202021-Mahecha%20Velandia.doc.pdf.txt6f65baf8b6cce6ce423c1a8e5891fb09MD526metadata only accessunicolmayor/5552oai:repositorio.unicolmayor.edu.co:unicolmayor/55522024-05-01 03:01:15.877An error occurred on the license name.|||https://creativecommons.org/licenses/by-nc-sa/4.0/open accessBiblioteca Digital Unicolmayorrepositorio@unicolmayor.edu.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